Complex Generics Made Simple
A deep-dive into respiratory & fermentation-based APIs
The field of complex generics is steadily gaining momentum in the biopharma world. The advantage is double-fold: to increase the value for the end-patient by addressing unmet therapeutic needs, and simultaneously enable a company’s differentiation from others.
In this new whitepaper, Complex Generics Made Simple, we deep-dive into two types of complex generics – respiratory and fermentation-based APIs.
You’ll discover:
• Why these segments are key for your portfolio
• The challenges associated with the development of respiratory and fermentation APIs
• What specialized skills and equipment are needed for development of these APIs
• How to remain competitive in 2022
Authors
![Card image cap](https://go.teva-api.com/l/293202/2022-01-11/wj15r3/293202/1641920456LsbgTbhq/respiratory_landing_ellipse_img_1.png)
Oshrat Frenkel, PhD, MBA
Director, Global R&D New Technologies, Innovation and Pre-Formulation
![Card image cap](https://go.teva-api.com/l/293202/2022-01-11/wj15yt/293202/1641920478P05UfZS6/respiratory_landing_ellipse_img_2.png)
Boglarka Szikszai, MSc
Manager of Biotechnological R&D, Fermentation SME
![Card image cap](https://storage.pardot.com/293202/1641920495cSou7nOz/respiratory_landing_ellipse_img_3.png)
Aleš Gavenda, PhD
Director Teva AMSO R&D, Czech Republic & Italy
![Card image cap](https://go.teva-api.com/l/293202/2022-01-11/wj16b3/293202/1641920531NP1heVM6/respiratory_landing_ellipse_img_4.png)
Eiron Benmor, MBA
Assoc. Director Product Management